Screener
Oruka Therapeutics, Inc. ORKA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $49,520 | $46,935 |
| Marketable securities, current | 339,309 | 290,109 |
| Prepaid expenses and other current assets | 6,420 | 6,813 |
| Total current assets | 395,249 | 343,857 |
| Marketable securities, long-term | 107,123 | 142,539 |
| Property and equipment, net | 318 | 288 |
| Operating lease right-of-use assets | 1,687 | 1,830 |
| Other non-current assets | 103 | 103 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s total current assets?
- Oruka Therapeutics, Inc. (ORKA) reported total current assets of $395.25M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total current assets changed year-over-year?
- Oruka Therapeutics, Inc.'s total current assets increased by 12.3% year-over-year, from $352.08M to $395.25M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total current assets has grown at a 47.1% compound annual growth rate (CAGR), from $49.97M to $343.86M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Oruka Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude